Pharmaron tests market appetite for HK IPO
Pharmaron Beijing Co, a Chinese pharmaceutical research and development service platform, started testing investor appetite for its IPO on Monday.
CLSA, Goldman Sachs and Orient Capital are the sponsors for the Hong Kong listing. There is no timing yet on when bookbuilding will kick off, but companies tend to gauge market feedback for a couple of weeks before starting to take orders.About 90% of the company’s listing ...
Please take a trial or subscribe to access this content.
Contact our subscriptions team to discuss your access: firstname.lastname@example.org